BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3879815)

  • 1. Role of the complement anaphylatoxins in inflammation and hypersensitivity reactions in the lung.
    Stimler-Gerard NP
    Surv Synth Pathol Res; 1985; 4(5-6):423-42. PubMed ID: 3879815
    [No Abstract]   [Full Text] [Related]  

  • 2. C5a: a mediator of chemotaxis and cellular release reactions.
    Gerard C; Hugli TE
    Kroc Found Ser; 1981; 14():147-60. PubMed ID: 6975805
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure and function of the anaphylatoxins.
    Hugli TE
    Springer Semin Immunopathol; 1984; 7(2-3):193-219. PubMed ID: 6387982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
    Hugli TE
    Crit Rev Immunol; 1981 Feb; 1(4):321-66. PubMed ID: 7037298
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the anaphylatoxins on circulation.
    Marceau F; Lundberg C; Hugli TE
    Immunopharmacology; 1987; 14(2):67-84. PubMed ID: 2828271
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological activities of complement-derived peptides.
    Damerau B
    Rev Physiol Biochem Pharmacol; 1987; 108():151-206. PubMed ID: 3306876
    [No Abstract]   [Full Text] [Related]  

  • 8. Anaphylatoxins: C3a and C5a.
    Hugli TE; Müller-Eberhard HJ
    Adv Immunol; 1978; 26():1-53. PubMed ID: 358800
    [No Abstract]   [Full Text] [Related]  

  • 9. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement split products and the pathogenesis of SLE.
    Abramson SB; Weissmann G
    Hosp Pract (Off Ed); 1988 Dec; 23(12):45-56. PubMed ID: 3142905
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F; Hugli TE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
    Greer J
    Enzyme; 1986; 36(1-2):150-63. PubMed ID: 3491754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
    Stimler-Gerard NP
    Complement; 1986; 3(3):137-51. PubMed ID: 3026723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J
    Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemistry and biology of anaphylatoxins.
    Hugli TE
    Complement; 1986; 3(3):111-27. PubMed ID: 3542363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
    Nagata S; Glovsky MM
    J Allergy Clin Immunol; 1987 Jul; 80(1):24-32. PubMed ID: 3496373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man.
    Jürgensen H; Behrendt H; Damerau B; Schmutzler W
    Agents Actions; 1986 Apr; 18(1-2):153-4. PubMed ID: 2425572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA; Steiger G; Paccaud JP
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.